CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alkermes, Inc. (Nasdaq: ALKS) today announced financial results for its first quarter of fiscal 2008. Financial highlights for the quarter ended June 30, 2007 include: * Fourth consecutive profitable quarter on a GAAP basis, with net income of $8.7 million. * Record quarterly revenues of $68.9 million. Worldwide sales of RISPERDAL® CONSTA® by Janssen-Cilag (Janssen) were $278.7 million.
